United States Immigration and Customs Enforcement is leveraging Palantir’s generative artificial intelligence tools to sort and summarize immigration enforcement tips from its public submission form, ...
Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...
This camper was able to pass the tests but their algorithm didn't perform a swap of the smallest element and the first unsorted element. def selection_sort(items ...
Objective: The aim of this study was to compare clinical outcomes between total arch replacement (TAR) and thoracic endovascular aortic repair (TEVAR) using Najuta in patients with aortic arch ...
Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...
UNDP People for 2030: People are our greatest asset. At UNDP, our People for 2030 strategy recognizes that our greatest asset is our people. As we embrace AI to enhance recruitment and workplace ...
An Army program for selecting unit commanders that a spokesman for defense chief Pete Hegseth condemned as "woke" selected White men for command roles at a higher rate than women and minority officers ...
The Command Assessment Program, or CAP, was used to “facilitate(s) the selection of battalion and brigade commanders, brigade command sergeants major, and medical service corps and acquisition corps ...
In a recent social media post, Peter Ray, senior director of medicinal chemistry at Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), drew attention to a new article in WIRED from Veronique Greenwood ...
Recursion, a clinical-stage TechBio company, has successfully acquired Rallybio’s entire interest in their joint ENPP1 inhibitor program (REV102) aimed at treating hypophosphatasia (HPP), a rare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results